Presentations

Monday, 14 June 2010 08:55 |

Wednesday May 19
Review of purpose and the agenda	Gil Veith
Levels of Assessment in the Canadian Environmental Protection Act	Kathy Hughes
In silico, in vitro, and in vivo methods as alternatives to the carcinogenicity bioassay	Romualdo Benigni
Predicting cancer endpoints using MultiCase	Gilles Klopman
Identifying genotoxic and nongenotoxic carcinogens with cell transformation assays	Paule Vasseur
Identifying major stress pathways	Ram Ramabhadran
Identifying carcinogens using Oncologic	Yin-tak Woo
In Silico Methods for Predicting Chromasomal Endpoints	Jay Niemela
Integrating Adverse Outcome Pathways into the OECD (Q)SAR Application Toolbox	Terry Schultz
Thursday May 20
Summary of Day One and Agenda	Gil Veith
Forming Chemical Categories for Cancer Endpoints	Ovanes Mekenyan
Modulation of QSAR sensitivity / specificity	Romualdo Benigni
Simulating of in vivo metabolism taking into account detoxification logics	Ovanes Mekenyan
Friday May 21
Discussion of approaches for bridging the in vitro/in vivo gap	Romualdo Benigni

Last Updated (Monday, 14 June 2010 09:19)

Strategic Design of Alternative Methods to Reduce Animal Testing